Sam Koppelman

The stock previously crashed due to accounting delays and delisting fears. Hunterbrook's investigation found the technology (weapons detection) works effectively in schools/stadiums and the accounting error was de minimis ($4M). Currently, the stock is selling off again in sympathy with software stocks and Axon (AXON), despite Evolv being a hardware/infrastructure play. The speaker notes the market is "indiscriminate" and implies the current sell-off is unjustified given the product's sticky demand (school safety). Fundamental value play; the business is real and growing despite market perception of it being a "fraud" or "software" stock. Regulatory scrutiny (SEC/FTC) persists; management fails to execute the turnaround.